Patent 11390856 was granted and assigned to DNA Script on July, 2022 by the United States Patent and Trademark Office.
The present invention relates to variant of Family A polymerases able to synthesize a nucleic acid fragment without template and to incorporate a reversible modified terminator nucleotide during the nucleic acid fragment synthesis. The present invention further relates to uses thereof for enzymatic synthesis of nucleic acid molecules.